Judge Questions Eagle's Orphan Drug Market Exclusivity

A D.C. Circuit judge appeared unconvinced by Eagle Pharmaceuticals' assertion that Congress unambiguously gave the U.S. Food and Drug Administration discretion to grant orphan drug exclusivity to multiple sponsors of a...

Already a subscriber? Click here to view full article